Welcome to ATAC (AIDS Treatment Activists Coalition) Online
WELCOME
We are a National Coalition of AIDS Activists, many living with HIV/AIDS, working together to end the AIDS epidemic by advancing research on HIV/AIDS.
Bristol-Myers Squibb

ATAC DDC Liaisons: Robert Levaro and Morris Jackson

CONTACT INFORMATION

Bristol-Myers Squibb Patient and Community Affairs

Michele Kofman, MPH
Patient and Community Affairs Manager, NYC/Northern NJ
Email: [email protected]
Phone: 1-800-492-7016 x 1409

Heshie Zinman
Patient and Community Affairs Manager, Northeast
Email: [email protected]
Phone: 1-800-492-7016 x 1423

Tom Millner
Patient and Community Affairs Manager, Southeast
Email: [email protected]
Phone: 1-800-492-7016 x 1415

Larry Wolf
Patient and Community Affairs Manager, Central States
Email: [email protected]
Phone: 1-800-492-7016 x 1422

Amy Valenzuela
Patient and Community Affairs Manager, Southwest
Email: [email protected]
Phone: 1-800-492-7016 x 1421

Steve Oxendine
Patient and Community Affairs Manager, Northwest
Email: [email protected]
Phone: 1-800-492-7016 x 1416

Jessica Riviere
Associate Director of Advocacy
Email: [email protected]
Phone: (609) 897-2433
Fax: (609) 897-6441

David Richwine, RN, BSN
Patient and Community Affairs Manager, Mid-Atlantic
Email: [email protected]
Phone: (917) 796-2369
Phone/Fax: (215) 238-9230

PRODUCT INFORMATION

  1. FDA-Approved Products:
    Nucleoside analog reverse transcriptase inhibitors: didanosine (ddI, Videx®, Videx® EC enteric coated), stavudine (d4T, Zerit®)
    Non-nucleoside reverse transcriptase inhibitor: efavirenz (Sustiva®)
    Antineoplastic agent (enhances ddI activity): hydroxyurea (Hydrea®)
  2. Products in Clinical Trials:Non-nucleoside reverse transcriptase inhibitor: BMS-083
    Hepatitis B polymerase inhibitor: Entecavir

Web pages:

KEY PERSONNEL

BMS Virology, Plainsboro, NJ

  • Jeff Hatfield, Sr. Vice President
  • Tim Ravenscroft, Vice President, Strategy and Operations
  • Antony Charles, Vice President, US Marketing
  • Michael R. Stevens, PharmD, Vice President, US Medical Affairs

BMS Pharmaceutical Research Institute (PRI)

  • Rich Colonno, MD, Vice President, Infectious Disease Drug Discovery
  • Steve Schnittman, MD, Vice President, Full Development Team Champion, Atazanavir
  • Deborah Dehertogh, MD, Vice President, Global Development Champion, Entecavir
  • Nancy Ruiz, MD, Group Director, Clinical Design and Evaluation
  • Michael Giordano, MD, Director, Clinical Research
  • Elizabeth Cooney, MD, Associate Director, Clinical Research
  • Helena Brett- Smith, MD, Associate Director, Clinical Research

Secure the Future

  • Amadou Diarra, Senior Director